BOK Financial’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,692
Closed -$218K 909
2022
Q1
$218K Sell
8,692
-625
-7% -$19.1K ﹤0.01% 906
2021
Q4
$334K Sell
9,317
-8
-0.1% -$320 0.01% 800
2021
Q3
$397K Buy
+9,325
New +$384K 0.01% 758
2021
Q1
$392K Hold
9,608
0.01% 737
2020
Q4
$435K Sell
9,608
-277
-3% -$10.5K 0.01% 694
2020
Q3
$350K Sell
9,885
-288
-3% -$10.4K 0.01% 693
2020
Q2
$384K Buy
10,173
+243
+2% +$8.01K 0.01% 690
2020
Q1
$287K Sell
9,930
-916
-8% -$37.1K 0.01% 703
2019
Q4
$562K Sell
10,846
-191
-2% -$11.1K 0.01% 676
2019
Q3
$606K Sell
11,037
-1,965
-15% -$101K 0.01% 623
2019
Q2
$528K Sell
13,002
-1,914
-13% -$69.8K 0.01% 657
2019
Q1
$451K Hold
14,916
0.01% 701
2018
Q4
$501K Buy
14,916
+3,511
+31% +$127K 0.01% 617
2018
Q3
$481K Buy
11,405
+281
+3% +$11.1K 0.01% 688
2018
Q2
$356K Sell
11,124
-11
-0.1% -$453 0.01% 758
2018
Q1
$554K Buy
11,135
+270
+2% +$15.3K 0.02% 618
2017
Q4
$586K Sell
10,865
-177
-2% -$9.8K 0.02% 624
2017
Q3
$640K Buy
11,042
+1,829
+20% +$95.6K 0.02% 598
2017
Q2
$455K Hold
9,213
0.01% 652
2017
Q1
$400K Buy
9,213
+4,768
+107% +$228K 0.01% 698
2016
Q4
$218K Buy
+4,445
New +$206K 0.01% 817

Other funds holding ANIK